175 related articles for article (PubMed ID: 29324997)
1. Skin lighteners and hair relaxers as risk factors for breast cancer: results from the Ghana breast health study.
Brinton LA; Figueroa JD; Ansong D; Nyarko KM; Wiafe S; Yarney J; Biritwum R; Brotzman M; Thistle JE; Adjei E; Aitpillah F; Dedey F; Edusei L; Titiloye N; Awuah B; Clegg-Lamptey JN; Wiafe-Addai B; Vanderpuye V
Carcinogenesis; 2018 Apr; 39(4):571-579. PubMed ID: 29324997
[TBL] [Abstract][Full Text] [Related]
2. Relation of circulating estrogens with hair relaxer and skin lightener use among postmenopausal women in Ghana.
Geczik AM; Falk RT; Xu X; Wiafe-Addai B; Yarney J; Awuah B; Biritwum R; Vanderpuye V; Dedey F; Adjei E; Aitpillah F; Osei-Bonsu E; Oppong J; Titiloye N; Edusei L; Nyarko K; Clegg-Lamptey JN; Wiafe S; Ansong D; Ahearn TU; Figueroa J; Garcia-Closas M; Brinton LA; Trabert B
J Expo Sci Environ Epidemiol; 2023 Mar; 33(2):301-310. PubMed ID: 34992224
[TBL] [Abstract][Full Text] [Related]
3. Hair product use and breast cancer incidence in the Black Women's Health Study.
Coogan PF; Rosenberg L; Palmer JR; Cozier YC; Lenzy YM; Bertrand KA
Carcinogenesis; 2021 Jul; 42(7):924-930. PubMed ID: 34013957
[TBL] [Abstract][Full Text] [Related]
4. Hair product use and breast cancer risk among African American and White women.
Llanos AAM; Rabkin A; Bandera EV; Zirpoli G; Gonzalez BD; Xing CY; Qin B; Lin Y; Hong CC; Demissie K; Ambrosone CB
Carcinogenesis; 2017 Sep; 38(9):883-892. PubMed ID: 28605409
[TBL] [Abstract][Full Text] [Related]
5. Hair relaxers not associated with breast cancer risk: evidence from the black women's health study.
Rosenberg L; Boggs DA; Adams-Campbell LL; Palmer JR
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1035-7. PubMed ID: 17507635
[TBL] [Abstract][Full Text] [Related]
6. The pH of lye and no-lye hair relaxers, including those advertised for children, is at levels that are corrosive to the skin.
Sishi VNB; Van Wyk JC; Khumalo NP
S Afr Med J; 2019 Nov; 109(12):941-946. PubMed ID: 31865956
[TBL] [Abstract][Full Text] [Related]
7. Use of hair products in relation to ovarian cancer risk.
White AJ; Sandler DP; Gaston SA; Jackson CL; O'Brien KM
Carcinogenesis; 2021 Oct; 42(9):1189-1195. PubMed ID: 34173819
[TBL] [Abstract][Full Text] [Related]
8. Hair product use and the risk of breast cancer in young women.
Cook LS; Malone KE; Daling JR; Voigt LF; Weiss NS
Cancer Causes Control; 1999 Dec; 10(6):551-9. PubMed ID: 10616824
[TBL] [Abstract][Full Text] [Related]
9. Hair relaxer use and risk of uterine cancer in the Black Women's Health Study.
Bertrand KA; Delp L; Coogan PF; Cozier YC; Lenzy YM; Rosenberg L; Palmer JR
Environ Res; 2023 Dec; 239(Pt 1):117228. PubMed ID: 37821068
[TBL] [Abstract][Full Text] [Related]
10. Factors contributing to delays in diagnosis of breast cancers in Ghana, West Africa.
Brinton L; Figueroa J; Adjei E; Ansong D; Biritwum R; Edusei L; Nyarko KM; Wiafe S; Yarney J; Addai BW; Awuah B; Clegg-Lamptey JN;
Breast Cancer Res Treat; 2017 Feb; 162(1):105-114. PubMed ID: 28025716
[TBL] [Abstract][Full Text] [Related]
11. Impact of hair relaxers in women in Nakuru, Kenya.
Etemesi BA
Int J Dermatol; 2007 Oct; 46 Suppl 1():23-5. PubMed ID: 17919201
[TBL] [Abstract][Full Text] [Related]
12. Hair dye and chemical straightener use and breast cancer risk in a large US population of black and white women.
Eberle CE; Sandler DP; Taylor KW; White AJ
Int J Cancer; 2020 Jul; 147(2):383-391. PubMed ID: 31797377
[TBL] [Abstract][Full Text] [Related]
13. Hair relaxer use and risk of uterine leiomyomata in African-American women.
Wise LA; Palmer JR; Reich D; Cozier YC; Rosenberg L
Am J Epidemiol; 2012 Mar; 175(5):432-40. PubMed ID: 22234483
[TBL] [Abstract][Full Text] [Related]
14. Use of permanent hair dyes and risk of breast cancer.
Green A; Willett WC; Colditz GA; Stampfer MJ; Bain C; Rosner B; Hennekens CH; Speizer FE
J Natl Cancer Inst; 1987 Aug; 79(2):253-7. PubMed ID: 3474457
[TBL] [Abstract][Full Text] [Related]
15. The globalization of whitening: prevalence of skin lighteners (or bleachers) use and its social correlates among university students in 26 countries.
Peltzer K; Pengpid S; James C
Int J Dermatol; 2016 Feb; 55(2):165-72. PubMed ID: 26472662
[TBL] [Abstract][Full Text] [Related]
16. 'Relaxers' damage hair: evidence from amino acid analysis.
Khumalo NP; Stone J; Gumedze F; McGrath E; Ngwanya MR; de Berker D
J Am Acad Dermatol; 2010 Mar; 62(3):402-8. PubMed ID: 20159306
[TBL] [Abstract][Full Text] [Related]
17. Ten pearls every dermatologist should know about the appropriate use of relaxers.
Richardson V; Agidi AT; Eaddy ER; Davis LS
J Cosmet Dermatol; 2017 Mar; 16(1):9-11. PubMed ID: 27472987
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of breast cancer and hair dyes.
Wynder EL; Goodman M
J Natl Cancer Inst; 1983 Sep; 71(3):481-8. PubMed ID: 6577224
[TBL] [Abstract][Full Text] [Related]
19. Design considerations for identifying breast cancer risk factors in a population-based study in Africa.
Brinton LA; Awuah B; Nat Clegg-Lamptey J; Wiafe-Addai B; Ansong D; Nyarko KM; Wiafe S; Yarney J; Biritwum R; Brotzman M; Adjei AA; Adjei E; Aitpillah F; Edusei L; Dedey F; Nyante SJ; Oppong J; Osei-Bonsu E; Titiloye N; Vanderpuye V; Brew Abaidoo E; Arhin B; Boakye I; Frempong M; Ohene Oti N; Okyne V; Figueroa JD
Int J Cancer; 2017 Jun; 140(12):2667-2677. PubMed ID: 28295287
[TBL] [Abstract][Full Text] [Related]
20. Hair product use, age at menarche and mammographic breast density in multiethnic urban women.
McDonald JA; Tehranifar P; Flom JD; Terry MB; James-Todd T
Environ Health; 2018 Jan; 17(1):1. PubMed ID: 29301538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
